Investors

19 March 2013

Media Release

Microskin PLC admitted to trade on GXG exchange

BRISBANE, Australia – Microskin PLC, a second skin technology company, announced today that it had been admitted to trading on the GXG Markets OTC immediately under the symbol  MSKN.

The company produces a revolutionary simulated second skin individually formulated to color correct a range of conditions such as dermatitis, eczema, psoriasis and vitiligo.

Microskin PLC’s wholly owned subsidiary, Microskin International, has already achieved considerable success both in Australia and overseas including establishing franchises in the US, Europe, the Middle East and Indonesia.

Executive chairman, Barry Amor, says admittance to the GXG was a major milestone in the company’s eight-year history.

“We have been at the forefront of the research and development of a second-skin technology which helps people suffering from all sorts of skin conditions,” Mr Amor says.

“It has required a lot of hard work and effort to bring us to where we are now which includes a sizeable international franchise network.

“Being able to trade on an international market will not only give us a more competitive environment for raising capital and trading of shares, but also takes us into a new phase of expansion.”

Microskin appointed first quotation introduction partners Stepping Stone Equity to complete the process.

For more information visit www.microskin.com.au

Australian second skin technology company to list on UK exchange

Media Release:

27 February 2013

Australian second skin technology company to list on UK exchange
Australian skin simulation technology company Microskin has announced its intention to list
on the UK based GXG exchange.

The company produces a revolutionary simulated second skin individually formulated to
color correct a range of conditions such as dermatitis, eczema, psoriasis and vitiligo.

Microskin has already achieved considerable success both in Australia and overseas
including establishing franchises in the US, Europe, the Middle East and Indonesia.

The Executive Chairman, Barry Amor, says Microskin is now in a position to be able to list on
an exchange, and the GXG offered the best initial option for international expansion.

“Microskin’s listing will provide the necessary capital to support our international expansion
plans, particularly to establish further franchises,” Mr Amor says.

“The GXG is a European regulated market and provides a more competitive environment for
raising capital and trading of shares, especially on a global scale.

“It will also give us access to a much larger consumer base, so all these factors make it an
attractive option to list.”

Microskin has appointed corporate advisors Stepping Stone Equity to complete the process
and to finalise a prospectus to comply with the exchange’s official list, paving the way for a
dual listing on the Frankfurt Stock Exchange.

Mr Amor says Microskin’s successful and profitable track record over the past eight years
has enabled it to build a sizeable franchise network, however liquidity in the company is
required for further expansion.

“While we have achieved considerable domestic and international success to date, we are
now focussing our energies on new markets which will give us a far greater opportunity to
further our expansion plans,” Mr Amor says.

“We are already well underway with negotiations for a number of new franchise agreements
and product development to supplement our flagship offering.

“Our listing strategy will provide us with both the capital and opportunities to continue our
research and development and help to secure our place as a dominant player in our industry
worldwide.”

The listing proposal has already been presented to Microskin shareholders for final approval
and is expected to be completed in the coming days.
For more information or to register interest in Microskin’s listing visit
www.microskin.com.au

ENDS

For all media enquiries contact Bruce Nelson on +61 (0) 423 403 449.

About Microskin

The concept of Microskin, a world-first skin simulation technology, was originally conceived
after realising that make-up was the only method of concealing or camouflaging skin
conditions. What transpired after many years of research into cosmetic chemistry as well as
developing specially designed software used to read human skin, was a system to develop a
spray-on simulated application individually formulated for each client’s skin. Microskin will
not rub off, is completely waterproof, allows the skin to breath and sweat, and lasts for
several days. Since the opening of its first clinic in Brisbane in July 2005, Microskin has
assisted people from all over the world with skin related conditions such as, vitiligo,
birthmarks, burns, eczema, lupus, keloid scarring.